CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Guangxi LiuYao Group Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Guangxi LiuYao Group Co Ltd
No. 68, Guantang Avenue
Phone: +86 7722566078p:+86 7722566078 LIUZHOU, GUX  545000  China Ticker: 603368603368
Business Summary
Guangxi LiuYao Group Co Ltd, formerly Guangxi Liuzhou Pharmaceutical Co Ltd, is a China-based company mainly engaged in the sales of pharmaceuticals. The Company is mainly engaged in three businesses. The pharmaceutical wholesale business mainly distributes pharmaceutical products to medical and health institutions at all levels, pharmaceutical distribution enterprises and chain pharmacies. The pharmaceutical retail business provides sales and health services of various pharmaceutical products, medical devices and other pharmaceutical products to individual consumers through terminal pharmacies. The pharmaceutical industry business is mainly engaged in the production and research and development of pharmaceuticals and medical devices. The Company is also engaged in supply chain value-added services, pharmaceutical Internet services, terminal health services, etc.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202312/31/2022Yes----

Industries
SIC Code Description
5122 Drugs, drug proprietaries, and druggists' sundries
5912 Drug stores and proprietary stores
7389 Business services, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, President ChaoyangZhu 57 3/30/2023 3/27/2017
Chief Financial Officer, Vice President XiangxingZeng 3/30/2023 3/30/2023
Vice President, Secretary of the Board WenjieShen 55 3/30/2023
10 additional Officers and Directors records available in full report.

General Information
Number of Employees: 5,162 (As of 12/31/2022)
Outstanding Shares: 362,193,871 (As of 3/14/2024)
Shareholders: 25,089
Stock Exchange: SHA
Fax Number: +86 7722566078


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 19, 2024